| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 10/06/2004 | EP1100534A4 Equine system for non-surgical artificial insemination |
| 10/06/2004 | EP0972017B1 Efficient nuclear transfer using fetal fibroblasts |
| 10/06/2004 | CN1169824C Polytype gene of MXA protein and application thereof |
| 10/06/2004 | CN1169434C Tem-sensitive lethality male silkworm breeding method |
| 10/06/2004 | CN1169433C Method for producing fodder by intensive stalk cultivating locust and its device for cultivating locust |
| 10/06/2004 | CN1169432C Thermostatic scorpion cultivating method |
| 10/05/2004 | US6800790 Method for maintenance and propagation of germline stem cells using members of the TFG-β family of growth factors |
| 10/05/2004 | US6800740 Variants of native growth hormones having non naturally occurring amino acid sequences or covalent modifications |
| 10/05/2004 | US6800471 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 10/05/2004 | US6800469 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens |
| 09/30/2004 | WO2004083445A2 Nucleic acid controlling the expression of a useful polypeptide in the posterior silk glands of a lepidoptera and application thereof |
| 09/30/2004 | WO2004083391A2 Targeted and regional cellular ablation in zebrafish |
| 09/30/2004 | WO2004082578A2 Use of soluble cd14 for treatment of diseases |
| 09/30/2004 | WO2004082517A2 Animal exhibiting ptsd-like behavior, per pct rule 4.3 |
| 09/30/2004 | WO2004082370A2 Cardiac-preferred genetic alteration of transgenic rabbits |
| 09/30/2004 | WO2004074445A9 Model for studying the role of genes in tumor resistance to chemotherapy |
| 09/30/2004 | WO2004064768A3 Animal model for alzheimer's disease |
| 09/30/2004 | WO2003072740A3 Novel type-1 cytokine receptor glm-r |
| 09/30/2004 | US20040194159 Cloning pigs using donor nuclei from differentiated cells |
| 09/30/2004 | US20040194158 Model for neurodegenerative disorders |
| 09/30/2004 | US20040194157 Animal with surgically modified gastrointestinal tract and method for study of weight reduction |
| 09/30/2004 | US20040194156 Transgenic aquatic invertebrates as a bioreactor for production of recombinant polypeptides |
| 09/30/2004 | US20040192630 nucleic acid constructs containing a HexB encoding element and a HexA encoding element; used in the treatment of Tay-Sachs and Sandoff disease; delivering a vector to a brain cell |
| 09/30/2004 | US20040191898 Trangenic diploid cell comprising mutation in kinase allele for use in screening modulator for treatment of anxiety, addiction, withdrawal syndrome, skeletal muscle spasms, convulsive seizures and epilepsy |
| 09/30/2004 | US20040191829 Comprises peptide associated with sugar transport protein for identifying modulators for treatment and prevention of cell proliferative disorder |
| 09/30/2004 | US20040191791 Comprises nucleotide sequences coding sodium voltage gated channels for identifying modulators for treatment of epilepsy; diagnosis of seizure disorders |
| 09/30/2004 | US20040191788 Method of encoding information in nucleic acids of a genetically enginerred organism |
| 09/30/2004 | US20040191230 Pharmaceutical composition for the diagnosis, prevention or treatment of a tumoral pathology comprising an agent modulating the polymerization state of actin |
| 09/30/2004 | US20040191229 Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase |
| 09/30/2004 | US20040191173 Metastasis models using green fluorescent protein (GFP) as a marker |
| 09/30/2004 | CA2519071A1 Targeted and regional cellular ablation in zebrafish |
| 09/29/2004 | EP1462102A1 A method for promoting gonadal growth in an animal |
| 09/29/2004 | EP1461614A2 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation |
| 09/29/2004 | EP1461610A2 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use |
| 09/29/2004 | EP1461450A1 T-bet compositions and methods of use thereof |
| 09/29/2004 | EP1461442A2 TRANSGENIC ANIMALS BEARING HUMAN Ig Lambda LIGHT CHAIN GENES |
| 09/29/2004 | EP1461430A2 Ovomucoid promoter and methods of use |
| 09/29/2004 | EP1461359A2 Novel anti-igf-ir antibodies and uses thereof |
| 09/29/2004 | EP1461052A2 Nucleic acid injected into hepatic vein lumen and delivered to primate liver |
| 09/29/2004 | EP1461023A2 Prospective identification and characterization of breast cancer stem cells |
| 09/29/2004 | EP1090116B1 Transgenic non-human animal which comprises an inactive peg3 gene, and the use thereof |
| 09/29/2004 | EP0742831B1 Transgenic non-human mammals with progressive neurologic disease |
| 09/29/2004 | CN1533436A Rapid method of selecting cells for gene disruption by homologous recombination |
| 09/29/2004 | CN1168383C Industrial reproduction technique of bombus spp. |
| 09/29/2004 | CN1168382C Method of cultivating rat with idiopathic arterial pressure sensitivity reflex function defect |
| 09/28/2004 | US6797499 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 09/28/2004 | US6796893 Apparatus and method for processing worms |
| 09/23/2004 | WO2004081218A1 Gene trap system |
| 09/23/2004 | WO2004081189A2 Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and organisms |
| 09/23/2004 | WO2004081052A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalopathies |
| 09/23/2004 | WO2004080416A2 Animal model simulating neurologic disease |
| 09/23/2004 | WO2004080406A2 Therapeutic compositions |
| 09/23/2004 | WO2004080162A2 Integrase mediated avian transgenesis |
| 09/23/2004 | WO2004066909A3 Method for identifying novel treatments of inflammatory disease in the gut |
| 09/23/2004 | WO2004063354A3 Compositions and methods for characterizing and regulating wnt pathways |
| 09/23/2004 | WO2004060052A3 Transgenic mice expressing human cd20 and/or cd16 |
| 09/23/2004 | WO2004051265A3 Fish disease models and uses thereof |
| 09/23/2004 | WO2004035082A3 Proteins involved in the regulation of energy homeostasis |
| 09/23/2004 | WO2004016751A3 Methods of treating neurodegenerative diseases |
| 09/23/2004 | WO2002095003A3 Phytases, nucleic acids encoding them and methods for making and using them |
| 09/23/2004 | US20040187172 Transgenic animal for screening therapeutic agents for brain tumors |
| 09/23/2004 | US20040187171 Expression vectors comprising nucleotide sequences coding cytokines for tissue specific expression and treatment of skin disorders |
| 09/23/2004 | US20040187170 Characterisation of gene function using double stranded RNA inhibition |
| 09/23/2004 | US20040187169 Identifying genes which effect cardiac function after or during oxygen deprivation for imaging and measuring movements of the heart; fluorescent microscopy; animal model for human heart disease |
| 09/23/2004 | US20040186275 Sarcomere binding polypeptide for use in diagnosis and treatment of diabetes and cardiomyopathies; diuretics; vasodilation; antiarrhythmic agents |
| 09/23/2004 | US20040185546 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 09/23/2004 | US20040185519 Calcium-independent phospholipase A2 induces ischemic ventricular arrhythmias and decreases infarction size |
| 09/23/2004 | US20040185508 Methods and reagents for modulating cholesterol levels |
| 09/23/2004 | US20040185503 Administering peroxisome proliferator-activated receptor agonist; assaying substance for up-regulating the expression of fatty acid-binding protein; glomerulonephritis, nephrotic syndrome, focal glomerulosclerosis |
| 09/23/2004 | US20040185465 for diagnosing a disease in an animal or susceptibility to a disease related to an over-expression of a phosphodiesterase; for drug screening antiinflammatory agents |
| 09/23/2004 | US20040185146 Methods for producing sialyloligosaccharides in a dairy source |
| 09/23/2004 | CA2518907A1 Gene trap system |
| 09/23/2004 | CA2518549A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalopathies |
| 09/23/2004 | CA2518475A1 Irna agents comprising asymmetrical modifications |
| 09/23/2004 | CA2518407A1 Animal model simulating neurologic disease |
| 09/22/2004 | EP1459727A1 Nonhuman model animal unresponsive to immunopotentiating synthetic compound |
| 09/22/2004 | EP1459624A2 Automatic system-based animal training device |
| 09/22/2004 | EP1458880A1 Isolation tool for viable c-kit expressing cells |
| 09/22/2004 | EP1458879A2 Method for producing a transgenic organism using a lentiviral expression vector such as eiav |
| 09/22/2004 | EP1458863A1 A system for stable expression of sirnas in mammalian cells |
| 09/22/2004 | EP1458860A2 Production of butyrylcholinesterases in transgenic mammals |
| 09/22/2004 | EP1458852A1 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells |
| 09/22/2004 | EP1458234A1 Disruption of the prostaglandin e synthase 2 gene |
| 09/22/2004 | EP1096955B1 Uses of antibodies to aminophospholipids for cancer treatment |
| 09/22/2004 | EP1019520A4 SCREENING METHODS TO DETECT mRNA TARGETS OF EDITING ENZYMES |
| 09/22/2004 | CN1531394A Methods |
| 09/22/2004 | CN1167795C Novel peptide, novel DNA and novel antibody |
| 09/22/2004 | CN1167793C Polypeptides encoded by human lipase-like gene, compositions and methods |
| 09/21/2004 | US6794154 Comprises assaying a test substance for the activity of up-regulating the expression of liver-type fatty acid-binding protein (l-fabp) in animal cells; peroxisome proliferator-activated receptor agonists; |
| 09/21/2004 | US6794145 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 09/21/2004 | US6794132 Human antibodies |
| 09/16/2004 | WO2004078985A1 Animal model for the fast identification of pharmaceutical active compounds in vivo |
| 09/16/2004 | WO2004078984A1 Animal model for the fast identification of pharmaceutical active compounds in vivo |
| 09/16/2004 | WO2004078939A2 REGULATION OF Mdm2 FUNCTION |
| 09/16/2004 | WO2004078925A2 Methods and compositions for treating and preventing neurodegenerative diseases |
| 09/16/2004 | WO2004078916A2 In vitro micro-organs, and uses related thereto |
| 09/16/2004 | WO2004078140A2 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF |
| 09/16/2004 | WO2004072227A3 Animal testing procedure |
| 09/16/2004 | WO2004067753A3 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof. |
| 09/16/2004 | WO2004067696A3 Interspecies embryonic stem cells |